Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Table of Contents

December 01, 2001; Volume 68,Issue 12

From the Editor

  • You have access
    Bioterrorism: An unintended boost to public health?
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 971;

    If anything good comes of recent events, it might be rejuvination of America’s public health system, which has languished in recent years.

The Clinical Picture

  • You have access
    A 62-year-old man with an abnormal electrocardiogram
    Curtis M. Rimmerman, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 975-976;

    Questions and answers on the visible signs of diseases.

Review

  • Our new understanding of pulmonary alveolar proteinosis: What an internist needs to know
    You have access
    Our new understanding of pulmonary alveolar proteinosis: What an internist needs to know
    Peter Mazzone, MD, Mary Jane Thomassen, PhD and Mani Kavuru, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 977-993;

    Recent advances point to a defect in granulocyte-macrophage colony stimulating factor (GM-CSF) as a cause of this disease. New treatments are under study.

1-Minute Consult

  • When should central venous catheters be changed in the intensive care unit? Should there be a rigid time-based protocol for doing so?
    You have access
    When should central venous catheters be changed in the intensive care unit? Should there be a rigid time-based protocol for doing so?
    Stephen A. Mette, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 994-996;

    The decision is made case by case rather than on a time-based protocol. Proactive strategies can reduce the risk of infection.

Editorial

  • You have access
    Bioterrorism: What practicing physicians can do
    James C. Pile, MD and David L. Longworth, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 998-1000;

    Given the specter of biological terrorism, the medical system has much to learn and much to do to prepare.

Review

  • You have access
    Biological and chemical terrorism: Recognition and management
    Thomas P. Noeller, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1001-1016;

    Future terrorist attacks might involve a variety of chemical or biological agents, including nerve agents, blistering agents, hydrogen cyanide, ricin, anthrax, smallpox, plague, and botulinum toxin. Physicians are on the front line.

Interpreting Key Trials

  • You have access
    GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
    Derek P. Chew, MBBS and David J. Moliterno, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1017-1023;

    Recent trials addressed whether there are clinical differences among these drugs, whether their empiric use is justified in acute coronary syndromes, and whether they might allow for early invasive management in acute coronary syndromes.

Departments

  • You have access
    Index to Volume 68
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1024-1028;
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 68 (12)
Cleveland Clinic Journal of Medicine
Vol. 68, Issue 12
1 Dec 2001
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • The Clinical Picture
  • Review
  • 1-Minute Consult
  • Editorial
  • Review
  • Interpreting Key Trials
  • Departments
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Which ICU patients need stress ulcer prophylaxis?
Dactylitis from Mycobacterium intracellulare infection
Mondor disease of the breast
Dyspnea and cough in a lung transplant recipient
Atypical erythema as a clinical presentation of tinea incognito
Pigmented lesion on nail bed: Pseudo-Hutchinson sign
Hampton hump in acute pulmonary embolism
A brownish erythematous patch in the nipple-areola complex
The underappreciated role of documentation in improving COPD care
Oral hyperpigmentation with weakness and salt-craving
Glycemic targets in the ICU: A look back, and ahead
Unilateral pulmonary edema
Does my patient need an allergy evaluation for penicillin allergy?

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2022 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire